Riskpilot← Back to searchSign inGet full accessJackal läkarkonsult AB
ABActiveOrg 5592998479Bolmörtsgatan 4General medical practice activities · NACE 8621Est. 20210 employees
Revenue 2024
SEK 225K
-57% vs 2023
EBITDA margin
8.4%
-93% vs 2023
Equity ratio
28.7%
Financial strength
Net profit 2024
SEK 10K
-95% vs 2023
| Revenue | SEK 225K | -57% |
| EBITDA | SEK 19K | -93% |
| Net profit | SEK 10K | -95% |
| Total assets | SEK 164K | -46% |
| Equity | SEK 47K | -80% |
| Employees | 0 | — |
Legal name
Jackal läkarkonsult AB
Org number
5592998479
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
3 februari 2021
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall syssla med konsultverksamhet inom sjukvård och därmed förenlig verksamhet. Detta kommer att göras som läkare på jourcentraler samt vårdcentraler, främst i västra götaland.
Address
Bolmörtsgatan 4
Email
j_kalkan@icloud.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 232 | 378 | 521 | 225 |
| Staff expenses | — | — | −130 | — |
| EBITDA | 138 | 222 | 272 | 19 |
| Depreciation & amort. | −1 | −3 | −4 | −4 |
| EBIT | 137 | 219 | 268 | 15 |
| Net financials | — | — | −0 | −1 |
| Profit before tax | 137 | 219 | 268 | 14 |
| Tax | −29 | −47 | −56 | −4 |
| Net profit | 108 | 172 | 211 | 10 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 144 | 234 | 303 | 164 |
| Equity | 133 | 197 | 236 | 47 |
| Long-term debt | 0 | 0 | 0 | 62 |
| Short-term debt | 11 | 37 | 66 | 56 |
| Total debt | 11 | 37 | 66 | 118 |
EBITDA margin
8.4%
This company
15.8%
Market median
-47% vs market
20212024
Equity ratio
28.7%
This company
38.2%
Market median
-25% vs market
20212024
Return on equity
21.3%
This company
18.4%
Market median
+16% vs market
20212024
Net profit margin
4.4%
This company
8.1%
Market median
-46% vs market
20212024
Asset turnover
1.37×
This company
1.12×
Market median
+22% vs market
20212024
Debt / equity
2.49×
This company
0.62×
Market median
-302% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-02-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Former (4) | ||
| Deputy Board Member | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
| Board of Directors | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Jackal läkarkonsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nils Henrik Kristoffer Svensson | Deputy Board Member | 0 companies |
| Lina Anna Elisabeth Nordström | Deputy Board Member | 0 companies |
| Nina Marika Wodzinski | Board of Directors | 0 companies |
| Henrik Daniel Karlsson | Deputy Board Member | 0 companies |
| Jacob Kalkan | Board of Directors | 0 companies |
| Malin Margareta Palm | Deputy Board Member | 0 companies |